Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -10558.64x is 199% below its 1-year average of -3534.75x, near the low end of its 1-year range (-10558.64x–-20.88x).
As of the fiscal period ended Tuesday, December 31, 2019.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2019 (2019-12-31): -10558.64x.
INTEREST COVERAGE RATIO
-10558.64x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.63x
median of 452 covered companies
CURRENT VS SECTOR MEDIAN
-187276.13%
vs the sector median at left
Nkarta, Inc.
Market Cap
$172.78M
Interest Coverage Ratio
-10558.64x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.75M
Interest Coverage Ratio
-74.29x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
Interest Coverage Ratio
-48.66x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.75M
Interest Coverage Ratio
-36.67x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$171.71M
Interest Coverage Ratio
-38.13x
TTM Avg
21.71x
3Y Avg
21.71x
5Y Avg
21.71x
Market Cap
$169.85M
Interest Coverage Ratio
N/A
TTM Avg
8.41x
3Y Avg
7.29x
5Y Avg
7.29x
Market Cap
$176.86M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$166.35M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
2.28x
5Y Avg
2.28x
Market Cap
$178.89M
Interest Coverage Ratio
-2.21x
TTM Avg
15.94x
3Y Avg
15.94x
5Y Avg
15.94x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nkarta, Inc. (NKTX) | $172.78M | -10558.64x | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE)vs › | $172.75M | -74.29x | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -48.66x | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $173.75M | -36.67x | N/A | N/A | N/A |
| MediWound Ltd. (MDWD)vs › | $171.71M | -38.13x | 21.71x | 21.71x | 21.71x |
| Organogenesis Holdings Inc. (ORGO)vs › | $169.85M | N/A | 8.41x | 7.29x | 7.29x |
| Compass Therapeutics, Inc. (CMPX)vs › | $176.86M | N/A | N/A | N/A | N/A |
| OptimizeRx Corp. (OPRX)vs › | $166.35M | 2.28x | 2.28x | 2.28x | 2.28x |
| Journey Medical Corporation (DERM)vs › | $178.89M | -2.21x | 15.94x | 15.94x | 15.94x |
| Quanterix Corporation (QTRX)vs › | $165.58M | N/A | N/A | N/A | N/A |
Interest Coverage
-10558.6x
Debt/Equity
0.30
Current Ratio
7.98
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2019-12-31 | -10558.64x |
| 2019-09-30 | -20.88x |
| 2019-06-30 | -24.71x |
